1. Home
  2. CII vs EIKN Comparison

CII vs EIKN Comparison

Compare CII & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock Capital and Income Fund Inc.

CII

Blackrock Capital and Income Fund Inc.

HOLD

Current Price

$24.70

Market Cap

841.0M

Sector

Finance

ML Signal

HOLD

EIKN

Eikon Therapeutics Inc. Common Stock

N/A

Current Price

$10.13

Market Cap

731.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CII
EIKN
Founded
2004
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
841.0M
731.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CII
EIKN
Price
$24.70
$10.13
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$25.60
AVG Volume (30 Days)
68.5K
205.3K
Earning Date
01-01-0001
03-30-2026
Dividend Yield
6.17%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.44
$7.90
52 Week High
$26.17
$16.50

Technical Indicators

Market Signals
Indicator
CII
EIKN
Relative Strength Index (RSI) 74.42 47.41
Support Level $23.04 $8.24
Resistance Level $26.17 $12.16
Average True Range (ATR) 0.28 0.90
MACD 0.04 0.05
Stochastic Oscillator 98.70 48.10

Price Performance

Historical Comparison
CII
EIKN

About CII Blackrock Capital and Income Fund Inc.

Blackrock Enhanced Cap&Inc Fund, Inc is a closed-end management investment company. Its investment objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing in a portfolio of equity securities of U.S. and foreign issuers. It may invest directly in such securities or synthetically through the use of derivatives. It also seeks to achieve its investment objective by employing a writing (selling) call and put options.

Share on Social Networks: